Tryptophan Hydroxylase – Key Enzyme in Serotonin Synthesis
Tryptophan hydroxylase is an enzyme that catalyzes the first step in serotonin biosynthesis, converting the amino acid tryptophan into 5-hydroxytryptophan. It plays a central role in regulating mood, sleep, and gut function.
Things worth knowing about "Tryptophan Hydroxylase"
Tryptophan hydroxylase is an enzyme that catalyzes the first step in serotonin biosynthesis, converting the amino acid tryptophan into 5-hydroxytryptophan. It plays a central role in regulating mood, sleep, and gut function.
What is Tryptophan Hydroxylase?
Tryptophan hydroxylase (TPH) is an enzyme belonging to the group of monooxygenases. It catalyzes the rate-limiting step in the biosynthesis of serotonin (5-hydroxytryptamine, 5-HT) by hydroxylating the essential amino acid L-tryptophan to produce 5-hydroxytryptophan (5-HTP). This intermediate is then rapidly converted to serotonin by the enzyme aromatic L-amino acid decarboxylase.
Two distinct isoforms of the enzyme have been identified: TPH1, which is expressed primarily in the enterochromaffin cells of the gastrointestinal tract and in the pineal gland, and TPH2, which is predominantly found in the serotonergic neurons of the brainstem, particularly in the raphe nuclei.
Mechanism of Action
Tryptophan hydroxylase requires several cofactors to function:
- Tetrahydrobiopterin (BH4) as an electron donor
- Molecular oxygen (O2)
- Iron (Fe²⁺) at the active site of the enzyme
During the enzymatic reaction, a hydroxyl group (-OH) is introduced at the 5-position of the indole ring of L-tryptophan, yielding 5-HTP. This step is the bottleneck of the entire serotonin synthesis pathway, as enzyme activity and tryptophan availability directly determine how much serotonin the body can produce.
Biological Significance
Because serotonin plays a crucial role in a wide range of physiological and psychological processes, the activity of tryptophan hydroxylase has far-reaching effects:
- Mood regulation: Brain serotonin influences mood, emotional balance, and well-being.
- Sleep-wake cycle: TPH1 in the pineal gland supplies the substrate for melatonin synthesis.
- Gut function: TPH1 in the intestine produces the vast majority of the body's total serotonin, which regulates gastrointestinal motility.
- Blood coagulation: Platelet-derived serotonin contributes to vasoconstriction and blood clotting.
Clinical Relevance
Alterations in the activity or expression of tryptophan hydroxylase have been linked to several medical conditions:
Psychiatric Disorders
Genetic polymorphisms in the TPH1 and TPH2 genes have been associated with an increased risk of depression, anxiety disorders, bipolar disorder, and suicidality. Reduced TPH2 activity in the brain may lead to serotonin deficiency, contributing to depressive symptoms.
Gastrointestinal Disorders
Altered TPH1 activity in the gut has been described in conditions such as irritable bowel syndrome (IBS) and inflammatory bowel diseases. TPH1 inhibitors such as telotristat are used clinically in carcinoid syndrome to reduce excessive intestinal serotonin production.
Carcinoid Tumors
Neuroendocrine tumors known as carcinoids frequently overexpress TPH1 and produce excessive amounts of serotonin, leading to characteristic symptoms such as flushing, diarrhea, and cardiac complications.
Regulation of Tryptophan Hydroxylase
Enzyme activity is regulated at multiple levels:
- Substrate availability: The supply of L-tryptophan, which competes with other large neutral amino acids for transport across the blood-brain barrier, directly influences central serotonin synthesis.
- Phosphorylation: TPH can be phosphorylated and activated by kinases such as protein kinase A (PKA) and Ca²⁺/calmodulin-dependent protein kinase (CaM kinase).
- Feedback mechanisms: Serotonin itself can inhibit its own synthesis via presynaptic autoreceptors (5-HT1A, 5-HT1B).
- Gene expression: Hormonal signals, stress hormones (e.g., cortisol), and circadian rhythms modulate the transcription of TPH genes.
Pharmacological Relevance
Tryptophan hydroxylase is an important therapeutic target in modern pharmacotherapy:
- Telotristat ethyl (Xermelo): An oral TPH inhibitor approved for the treatment of diarrhea associated with carcinoid syndrome.
- Indirect modulation: Many antidepressants (e.g., SSRIs) do not directly target TPH but increase synaptic serotonin availability. Adequate dietary tryptophan intake is a prerequisite for their effectiveness.
- 5-HTP supplementation: As the direct product of the TPH reaction, 5-HTP is used as a dietary supplement to support serotonin synthesis, although clinical evidence remains limited.
References
- Walther, D. J. & Bader, M. (2003). A unique central tryptophan hydroxylase isoform. Biochemical Pharmacology, 66(9), 1673-1680. PubMed PMID: 14563489.
- Berger, M., Gray, J. A. & Roth, B. L. (2009). The expanded biology of serotonin. Annual Review of Medicine, 60, 355-366. PubMed PMID: 19630576.
- Kulke, M. H. et al. (2017). Telotristat ethyl, a tryptophan hydroxylase inhibitor for the treatment of carcinoid syndrome. Journal of Clinical Oncology, 35(1), 14-23. PubMed PMID: 28034064.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryhemiparesis
Antiphospholipid Syndrome
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Tryptophan Hydroxylase-en